Zimbabwe has rejected a major US health deal worth 367 million US dollars (£272m) over five years over Washington's demand for confidential information.
The decision was revealed following a government memo dated December was leaked, revealing that President Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesman has since stated that the United States was seeking health data for research and profit while was not willing to guarantee the resulting advantages from any future treatments.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged further negotiations to find a deal acceptable to all parties so the nation's vital HIV programme can proceed.
Broader Implications
This rejection comes after a similar case in neighbouring Kenya, where a court halted a related health funding agreement after concerns were filed about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and closed the key foreign aid agency.
USAID had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was pursuing government-to-government deals to enhance openness and responsibility.
According to statements, Sixteen African countries have so far signed similar agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," Tremont said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to share its biological resources and data for a long time, with no equivalent assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Put simply, our country would provide the basic resources for scientific discovery with no certainty that the resulting innovations would be accessible to our citizens if a future disease outbreak arise."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were undermining systems already established through the global health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme created to deal with future global health emergencies.
"This system is intended to guarantee that when a nation contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to further discussions with our American counterparts on how future co-operation could be designed in a manner that respects the sovereignty and interests of each country."
Medical Community Response
Medical experts stated it acknowledged the official position, but suggested that negotiations should continue given that a large portion of the nation's HIV programmes were funded by international support.
"Where specific concerns arise, such as those involving information security or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it added.
This impasse highlights the ongoing challenges between accepting vital international aid and safeguarding national sovereignty in an ever more data-driven world.